Desktop SEM in Pharmaceutical & Drug Delivery Research: 4 Key Studies

Pharmaceutical & Drug Delivery SEM Research Insights | NanoImages Blog

Research Insight: How Desktop SEMs Are Advancing Pharmaceutical Drug Delivery

February 15, 2026 • Research Insight • 5 min read

Desktop scanning electron microscopes are playing a growing role in pharmaceutical drug delivery research, providing the high-resolution surface imaging that formulation scientists need to verify microneedle geometry, confirm nanoparticle morphology, and validate transdermal delivery structures — all without sending samples to a central imaging facility. The following peer-reviewed studies illustrate how researchers are using SEC desktop SEMs across a range of drug delivery applications.

Polymeric Microarray Patches for Antimalarial Delivery

Anjani QK et al. “Polymeric microarray patches for transdermal delivery of amodiaquine and artesunate.” Materials Today Bio, 2025. Instrument: SNE-Alpha.

This study addressed a critical challenge in global health: delivering antimalarial combination therapy through a painless, needle-free route. The research team developed dissolving polymeric microarray patches loaded with amodiaquine and artesunate, two front-line antimalarial drugs. SEM imaging on the SNE-Alpha was essential for confirming the structural integrity of the microneedle arrays after fabrication, verifying uniform needle height and tip sharpness that directly affect skin penetration performance. The micrographs demonstrated well-defined conical needle geometries with consistent dimensions across the array, confirming that the manufacturing process produced patches capable of reliable transdermal drug delivery.

Microarray Patches for Psychedelic Microdosing

Fandino OE et al. “Application of microarray patches for transdermal administration of psychedelic drugs in micro-doses.” European Journal of Pharmaceutics, 2025. Instrument: SNE-Alpha.

As clinical interest in psychedelic-assisted therapy grows, precise dosing becomes paramount. This paper explored microarray patches as a controlled delivery mechanism for psychedelic compounds at micro-dose levels. The researchers used the SNE-Alpha to characterize patch morphology before and after drug loading, ensuring that the incorporation of active compounds did not compromise microneedle structural integrity. SEM imaging revealed that the loaded patches maintained sharp, uniform needle tips — a critical quality attribute for consistent skin insertion depth and, therefore, predictable drug absorption kinetics.

SmartReservoir Microneedles for Controlled Antidepressant Release

Abraham AM et al. “Controlled release of amitriptyline via transdermal route using SmartReservoirs and hydrogel-forming microneedles.” Biomaterials Advances, 2025. Instrument: SNE-Alpha.

Controlled release of psychiatric medications through the skin offers significant advantages over oral dosing, including bypass of first-pass metabolism and more stable plasma drug levels. This study combined SmartReservoir technology with hydrogel-forming microneedles to achieve sustained transdermal delivery of amitriptyline. Desktop SEM imaging was used to evaluate the microneedle array architecture, hydrogel swelling behavior, and the integration between reservoir and needle components. The high-resolution images confirmed that the hydrogel-forming needles maintained their mechanical structure during the swelling process that drives drug release, providing visual evidence supporting the proposed delivery mechanism.

Solid Lipid Nanoparticles for Dermal Drug Delivery

Shahraeini SS et al. “Atorvastatin solid lipid nanoparticles for dermal delivery.” AAPS PharmSciTech, 2020. Instrument: SNE-4500M.

Solid lipid nanoparticles (SLNs) represent a well-established platform for enhancing dermal penetration of poorly soluble drugs. In this work, researchers formulated atorvastatin-loaded SLNs for topical application and used the SNE-4500M desktop SEM to confirm particle morphology and size distribution. SEM micrographs revealed spherical nanoparticles with smooth surfaces and relatively narrow size distribution, consistent with dynamic light scattering measurements. The ability to quickly image nanoparticle batches on a desktop SEM allowed the team to screen multiple formulation variables — lipid type, surfactant concentration, and homogenization parameters — without waiting for access to a shared facility instrument.

Key Findings Across These Studies

  • Desktop SEMs provided the resolution needed to verify microneedle tip geometry (sub-10-micron features) critical to transdermal patch performance
  • Rapid imaging turnaround enabled iterative formulation development — researchers could fabricate, image, and refine within the same day
  • Both the SNE-Alpha and SNE-4500M produced publication-quality micrographs accepted by high-impact journals including Materials Today Bio, Biomaterials Advances, and AAPS PharmSciTech
  • SEM characterization was used alongside complementary techniques (FTIR, DSC, drug release testing) to build comprehensive formulation profiles

Why Desktop SEM Fits Drug Delivery Research

Drug delivery formulation is inherently iterative. Researchers routinely prepare dozens of patch or nanoparticle variants, adjusting polymer concentrations, drug loadings, and processing parameters. Each variant needs morphological verification. A desktop SEM sitting in the formulation lab — rather than a floor-standing instrument in a shared facility with a two-week booking queue — compresses the feedback loop from weeks to hours. That acceleration is reflected in the productivity of the research groups cited above, several of which published multiple papers using the same desktop SEM platform within a single year.

Explore how desktop SEM supports pharmaceutical research workflows, or contact us to discuss imaging needs for your drug delivery projects. Learn more about the SNE-Alpha platform used in these studies.

NanoImages Assistant

Online

Hi! I'm the NanoImages AI assistant. Ask me anything about our SNE-Alpha desktop SEM, applications, sample prep, or scheduling a demo.